Drug Trial Radar · NCT03447262
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
Last checked: Nov 19, 2026Latest source record: Jan 25, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
484
Actual
Start
Jul 13, 2018
Primary completion
Sep 9, 2020
Study completion Sep 9, 2020
Sponsor
- Lead sponsor
- Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
- Sponsor type
- Industry
- First posted
- Feb 27, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the long-term safety and tolerability of VX-659 in triple combination (TC) with tezacaftor (TEZ) and ivacaftor (IVA) in subjects with cystic fibrosis (CF) who are homozygous or heterozygous for the F508del mutation.
Conditions
- Cystic Fibrosis
Interventions
VX-659/TEZ/IVADrug
Fixed-dose combination tablets for oral administration qd in the morning.
IVADrug
IVA tablet qd in the evening.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety and Tolerability as Assessed by Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs)Time frame: From Day 1 up to 28 Days After Last Dose of Study Drug or to the Completion of Study Participation Date, Whichever Occurs First in the Current Study 659-105 (up to Week 100)
Locations
100 sites in 11 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Stanford University
Palo Alto, California
Children's Hospital Colorado
Aurora, Colorado
Hartford Hospital
Hartford, Connecticut
Yale New Haven Medical Center
New Haven, Connecticut
University of Miami Miller School of Medicine
Miami, Florida
Nicklaus Children's Hospital
Miami, Florida
Orlando Health, Inc.- Arnold Palmer Hospital for Children (APH)
Orlando, Florida
Johns Hopkins All Children's Hospital Outpatient Care Center
St. Petersburg, Florida
St. Luke's CF Center of Idaho
Boise, Idaho
Cystic Fibrosis Center of Chicago
Glenview, Illinois
Advocate Children's Hospital - Park Ridge / North Suburban Pulmonary and Critical Care Consultants
Niles, Illinois
Indiana Clinical Research Center, IU Health University Hospital
Indianapolis, Indiana
The University of Iowa Hospitals and Clinics
Iowa City, Iowa
University of Kentucky
Lexington, Kentucky
Kosair Charities Pediatric Clinical Research Unit
Louisville, Kentucky
Johns Hopkins Hospital
Baltimore, Maryland
Boston Children's Hospital
Boston, Massachusetts
UMass Memorial Medical Center
Worcester, Massachusetts
Michigan Medicine
Ann Arbor, Michigan
Spectrum Health Medical Group Adult Cystic Fibrosis Care Center
Grand Rapids, Michigan
University of Minnesota
Minneapolis, Minnesota
University of Mississippi Medical Center
Jackson, Mississippi
The Children's Mercy Hospital
Kansas City, Missouri
Washington University School of Medicine/ St. Louis Children's Hospital
St Louis, Missouri
Dartmouth Hitchcock, Manchester
Manchester, New Hampshire
Rutgers-Robert Wood Johnson Medical School
New Brunswick, New Jersey
Albany Medical College
Albany, New York
CF Therapeutics Development Center of Western New York
Buffalo, New York
Northwell Health, Long Island Jewish Medical Center
New Hyde Park, New York
Columbia University Medical Center
New York, New York
SUNY Upstate Medical University
Syracuse, New York
Clinical Research of Charlotte
Charlotte, North Carolina
Duke University Medical Center
Durham, North Carolina
Cincinnati Children's Hospital
Cincinnati, Ohio
Santiago Reyes, M.D.
Oklahoma City, Oklahoma
Oregon Health & Science University
Portland, Oregon
Drexel University College of Medicine / Drexel Adult Cystic Fibrosis Center
Philadelphia, Pennsylvania
Children's Hospital of Pittsburgh of UPMC
Pittsburgh, Pennsylvania
Sanford Children's Specialty Clinic
Sioux Falls, South Dakota
Showing 40 of 100 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.